Results 21 to 30 of about 3,602,513 (298)
Frontiers in Pharmacology, 2017 Background: Lipegfilgrastim (Lonquex®) has demonstrated to be non-inferior to pegfilgrastim (Neulasta®) in reducing the duration of severe neutropenia (SN) in patients with stage II−IV breast cancer.
Esse I. H. Akpo +3 more
doaj +1 more source
Business models of big pharma in Russia: A pharmaceutical value chain perspective
RUDN Journal of Economics, 2022 Large pharmaceutical companies (commonly referred to as Big Pharma) determine transformation trends in the global and national pharmaceutical market, make the largest investments in RD to create new original medicines, act as leaders in the processes of ...
Natalia A. Volgina
doaj +1 more source
RUDN Journal of Economics, 2023 Cross-border pharmaceutical value chains are expanding their presence in international production, including in the highly profitable RD link. Leading pharmaceutical companies, known as Big Pharma, are establishing contract relationships with research ...
Natalia A. Volgina, Na Li
doaj +1 more source
Pharmaceutical Market Structure in India & Competition Concerns
, 2020 Health Status of any country depends upon its preventive, curative, and promotive measures. But to implement these measures with available skilled human resources, and infrastructure, the growth of the pharmaceutical market is an essential one.
M. Chitra, Nand Kumar
semanticscholar +1 more source
International Journal of Environmental Research and Public Health, 2021 Pharmaceuticals enhance our quality of life; consequently, their consumption is growing as a result of the need to treat ageing-related and chronic diseases and changes in the clinical practice.
Omar Israel González Peña +2 more
semanticscholar +1 more source
Pharmaceutical Market and Drug Price Policy in India
Review of Development and Change, 2020 Drug prices and cost of healthcare are two major concerns globally. This entails to examine the structure and performance of domestic pharmaceutical industry and Indian market’s pricing policy of drugs.
V. Motkuri, R. Mishra
semanticscholar +1 more source
Pharmaceutical nanotechnology: from the bench to the market
Future Journal of Pharmaceutical Sciences, 2022 Nanotechnology is considered a new and rapidly emerging area in the pharmaceutical and medicinal field. Nanoparticles, as drug delivery systems, impart several advantages concerning improved efficacy as well as reduced adverse drug reactions.
Zaed M. Mazayen +4 more
semanticscholar +1 more source
The Korean Pharmaceutical Industry and the Expansion of the General Pharmaceuticals Market in the 1950-1960s [PDF]
Uisahak, 2015 After the Liberation, the Korean economy was dependent on relief supplies and aid after the ruin of the colonial regime and war. The pharmaceutical business also searched for their share in the delivery of military supplies and the distribution of relief
Kyu-Hwan SIHN
doaj +1 more source
Pharmaceutics, 2021 Recently, the electrospinning (ES) process has been extensively studied due to its potential applications in various fields, particularly pharmaceutical and biomedical purposes. The production rate using typical ES technology is usually around 0.01–1 g/h,
S. Omer +3 more
semanticscholar +1 more source
The Various Shapes of Innovation
Forum of Clinical Oncology, 2015 Background: Innovation is one of the most difficult words to define, especially when it comes to health technology. The aim of this article is to get a better understanding of the multi-dimensional facet of innovation, how this is valued by different ...
Roubou I., Alexopoulou D.K.
doaj +1 more source